Milestone Pharmaceuticals Announces Presentation of Data from Analysis of Etripamil Nasal Spray in Patients Experiencing Atrial Fibrillation with Rapid Ventricular Rate

/PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative...

Related Keywords

Canada ,Ukraine ,Montreal ,Quebec ,Toronto ,Ontario ,United States ,Russia ,Russian ,Americans ,David Pitts ,Jonathanp Piccini ,Joseph Oliveto ,Paul Dorian ,University Of Toronto ,Prnewswire Milestone Pharmaceuticals Inc ,Milestone Pharmaceuticals ,Us Securities Exchange Commission ,Exchange Commission ,Professor Of Medicine Population Health ,Milestone Pharmaceuticals Inc ,Centers For Disease ,Duke University Clinical Research Institute ,Nasdaq ,Heart Rhythm ,Chief Executive Officer ,Staff Cardiac Electrophysiologist ,Key Opinion Leader ,Population Health ,Cardiac Electrophysiology ,Duke University ,Duke Clinical Research ,Atrial Fibrillation ,Rapid Ventricular ,Disease Control ,Supraventricular Tachycardia ,Private Securities Litigation Reform Act ,Nc ,